-
EMA finds no suicide risk with GLP-1 diabetes, obesity drugs
15 Apr 2024 09:44 GMT
… medicines regulator.
Along with other world regulators – including the FDA … ’s older GLP-1 drug Saxenda (liraglutide) for … ’s Byetta (exenatide) and Bydureon (exenatide) and Sanofi’s … non-clinical studies, clinical trials, post-marketing surveillance data, …
-
Weight loss drugs like Ozempic not linked with suicidal thoughts, EU drugs regulator finds
12 Apr 2024 11:48 GMT
… ;s Suliqua, AstraZeneca's Bydureon and Novo's Rybelsus … EMA, as well as clinical trials and post-marketing surveillance data … by the U.S. Federal Drugs Agency, which announced in January … regarding more than a dozen drugs, including Ozempic, Wegovy and …
-
Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says
12 Apr 2024 15:42 GMT
… 1 RAs.
The FDA released an update stating that its preliminary … ’s AZN Byetta and Bydureon; Sanofi SA’s SNY … non-clinical studies, clinical trials, and post-marketing surveillance … information are needed. The medication companies will continue monitoring …
-
FDA Approved Drug Products Approval List March 2024
30 Mar 2024 10:39 GMT
… 47;06/2024 BYDUREON BCISENDA #209210 SUPPL-23 … 214369 ORIG-1 RIFAXIMIN NORWICH PHARMACEUTICALS INC Tentative Approval 03 … 761044 SUPPL-13 USTEKINUMAB JANSSEN BIOTECH Approval 03/18 … SUPPL-15 PRALSETINIB BLUEPRINT MEDICINES Labeling Approval 03…
-
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
26 Mar 2024 12:51 GMT
… Pharmaceuticals, with partner Alkermes, secured the 2012 approval of Bydureon® … development for the treatment of chronic weight … including those taking daily pills. Medication non-adherence, which … S. Food and Drug Administration (“FDA”); risks related to …
-
Ozempic, the happy drug? Study suggests weight-loss medications could reduce depression, anxiety
17 Feb 2024 11:42 GMT
… ) and exenatide (Byetta and Bydureon). (Getty Images)
"Losing … medications studied the effect on depression in the original clinical trials … GLP-1 drugs were shown to have antidepressant-like effects … become a first-line treatment for depression, but it …
-
Ozempic Not Linked with Suicidal Thoughts Finds EMA
16 Apr 2024 13:14 GMT
… the GLP-1 class of drugs. This follows reports last June … these medicines, namely Ozempic, Rybelsus, Wegovy, Victoza, Saxenda, Xultophy, Byetta, Bydureon, Lyxumia … from non-clinical studies, clinical trials, post-marketing surveillance data and …
-
Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio
28 Feb 2024 13:52 GMT
… development for the treatment of chronic weight management … is the active pharmaceutical ingredient in NPM-139 … (twice-daily injection) and Bydureon® (weekly injection) potentially … including those taking daily pills. Medication non-adherence, which …
-
Noom Med Reviews: Is It Right For You or Cheap GLP-1 Medication Prescriptions?
03 Feb 2024 00:35 GMT
… Features
There are other doctor-approved weight loss programs … GLP-1 medications like Ozempic, Victoza, Trulicity, Rybelsus, and Bydureon. A … hours.
Backed by Clinical Trials: Noom was developed by … Wegovy or a placebo treatment while following a calorie- …
-
Drug shortages challenge type 2 diabetes patients in the UK
27 Jan 2024 16:48 GMT
… GLP1RA semaglutide, for new treatment initiations and for those … Victoza, Saxenda, Byetta, and Bydureon, as listed in the … the parent company of Pharmaceutical Technology.
In addition to … reported shortages for ADHD medication and hormone-replacement therapies …